Skip to content
lifestyle.getpetsavvy.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Telix Pharmaceuticals Limited
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
April 14, 2026
Telix and Regeneron Announce Strategic Radiopharma Collaboration
April 13, 2026
Telix Strengthens Board with Additional Director Appointments
April 8, 2026
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
April 7, 2026
Telix Appoints David Gill as Non-Executive Director
April 1, 2026
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
March 9, 2026
Telix to Participate in Oppenheimer and TD Cowen Conferences
February 20, 2026
Telix Full Year Results 2025 Investor Webcast Notification
February 3, 2026
←
Previous Page
1
2
3